Translational Neuroscience (Oct 2022)

Prevalence of neurodegenerative/demyelinating disorders in patients with achalasia

  • Jerie Martin,
  • Vackova Zuzana,
  • Vojtech Zdenek,
  • Mares Jan,
  • Meluzinova Eva,
  • Krajciova Jana,
  • Vymazal Josef,
  • Cerna Hana,
  • Martinek Jan

DOI
https://doi.org/10.1515/tnsci-2022-0249
Journal volume & issue
Vol. 13, no. 1
pp. 361 – 368

Abstract

Read online

Esophageal achalasia is a primary motility disorder. Although the exact pathogenesis is unknown, autoimmune, and neurodegenerative processes seem to be involved similarly to neurodegenerative and/or demyelinating disorders (NDDs). We hypothesized that the prevalence of NDD may be higher among patients with achalasia and vice versa as the background pathogenetic mechanisms are similar.

Keywords